Literature DB >> 16794828

Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.

Artit Jinawath1, Yoshimitsu Akiyama, Yasuhito Yuasa, Chawalit Pairojkul.   

Abstract

PURPOSE: The extracellular signal-regulated kinase (ERK) 1/2 pathway plays important roles in the regulation of cell proliferation, differentiation and cell survival. The caudal-related homeobox protein CDX2 is essential for the development of the intestine, and is related to gastric and gallbladder cancers with the intestinal phenotype. However, the roles of ERK1/2 phosphorylation (pERK1/2) and CDX2 in cholangiocarcinogenesis remain unknown.
METHODS: We investigated the expression of pERK1/2, CDX2 and MUC2 in Thai cholangiocarcinoma (CCA) specimens by means of immunohistochemical staining, and compared the expression of these proteins with clinicopathological factors.
RESULTS: The pERK1/2 protein was expressed in 29 of 59 (49.2%) CCA cases. Interestingly, in tubular-type CCA, the frequency of pERK1/2 expression was associated with a higher grade of differentiation (P = 0.001). CDX2 expression was observed in 22 of the 59 (37.3%) CCA cases, showed a relationship with MUC2 expression (P = 0.001), and was much higher in papillary-type than tubular-type CCA (P = 0.002).
CONCLUSION: These results imply that pERK1/2 may be important for the differentiation of tubular-type CCA, while CDX2 is related to the intestinal phenotype of papillary-type CCA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794828     DOI: 10.1007/s00432-006-0129-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.

Authors:  H Suzuki; S Isaji; C Pairojkul; T Uttaravichien
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

2.  Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression.

Authors:  Hiroshi Yamamoto; Yun Qing Bai; Yasuhito Yuasa
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

Review 3.  Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

Authors:  F Chang; L S Steelman; J T Lee; J G Shelton; P M Navolanic; W L Blalock; R A Franklin; J A McCubrey
Journal:  Leukemia       Date:  2003-07       Impact factor: 11.528

4.  Cdx1 and cdx2 expression during intestinal development.

Authors:  D G Silberg; G P Swain; E R Suh; P G Traber
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

5.  Expression of homeodomain protein CDX2 in gallbladder carcinomas.

Authors:  Xiang-Song Wu; Yoshimitsu Akiyama; Toru Igari; Tohru Kawamura; Susumu Hiranuma; Toshikatsu Shibata; Kouji Tsuruta; Morio Koike; Shigeki Arii; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-11       Impact factor: 4.553

Review 6.  Control of gut differentiation and intestinal-type gastric carcinogenesis.

Authors:  Yasuhito Yuasa
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

7.  Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.

Authors:  Akashi Eda; Hiroyuki Osawa; Kiichi Satoh; Ichiro Yanaka; Ken Kihira; Yumiko Ishino; Hiroyuki Mutoh; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

Review 8.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

9.  EGF-induced proliferation of adult human pancreatic duct cells is mediated by the MEK/ERK cascade.

Authors:  Claude Rescan; Stéphanie Le Bras; Véronique H Lefebvre; Ulrik Frandsen; Tino Klein; Marco Foschi; Daniel G Pipeleers; Raphael Scharfmann; Ole D Madsen; Harry Heimberg
Journal:  Lab Invest       Date:  2005-01       Impact factor: 5.662

10.  ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.

Authors:  S Vicent; J M López-Picazo; G Toledo; M D Lozano; W Torre; C Garcia-Corchón; C Quero; J-C Soria; S Martín-Algarra; R G Manzano; L M Montuenga
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more
  10 in total

1.  Combination of celecoxib and PD184161 exerts synergistic inhibitory effects on gallbladder cancer cell proliferation.

Authors:  Min Deng; Yiyu Qin; Xiaodong Chen; Dapeng Li; Qiangwu Wang; Hailun Zheng; Lin Gu; Chaojing Deng; Yongju Xue; Danyu Zhu; Qizhi Wang; Jianchao Wang
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

2.  Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.

Authors:  Sumalee Obchoei; Kanlayanee Sawanyawisuth; Chaisiri Wongkham; Watchara Kasinrerk; Qizhi Yao; Changyi Chen; Sopit Wongkham
Journal:  Tumour Biol       Date:  2014-10-10

3.  Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.

Authors:  Artit Jinawath; Yoshimitsu Akiyama; Banchob Sripa; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-25       Impact factor: 4.553

4.  Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).

Authors:  Carsten Sticht; Kolja Freier; Karl Knöpfle; Christa Flechtenmacher; Susanne Pungs; Christof Hofele; Meinhard Hahn; Stefan Joos; Peter Lichter
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

5.  Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.

Authors:  Kawin Leelawat; Surang Leelawat; Siriluck Narong; Suradej Hongeng
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

6.  The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.

Authors:  Haowen Tang; Zhanbo Wang; Wenping Lv; Xuan Meng
Journal:  Intractable Rare Dis Res       Date:  2018-05

7.  Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.

Authors:  Xiao-Tong Wang; Wei-Yuan Wei; Fan-Biao Kong; Chao Lian; Wen Luo; Qiang Xiao; Yu-Bo Xie
Journal:  J Exp Clin Cancer Res       Date:  2012-11-26

8.  Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome.

Authors:  Qing-Long Li; Zhu-Lin Yang; Jie-Qiong Liu; Xiong-Ying Miao
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

9.  DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.

Authors:  Jiliang Shen; Senjun Zhou; Liang Shi; Xiaolong Liu; Hui Lin; Hong Yu; Jiacheng Tang; Tunan Yu; Xiujun Cai
Journal:  Oncotarget       Date:  2017-02-14

10.  Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.

Authors:  Qinglong Li; Zhulin Yang
Journal:  J Exp Clin Cancer Res       Date:  2009-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.